Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Peptimmune grants Novartis exclusive option to license PI-2301 for MS

Jan. 19, 2009

Scientists at Janssen describe new analgesic FAAH inhibitors in recent patent

Jan. 19, 2009

Novel mgluR5 positive allosteric modulators developed at GSK for schizophrenia

Jan. 19, 2009

Analgesic calcium channel alpha2-delta subreceptor ligands claimed by Kyowa Hakko Kirin

Jan. 19, 2009

Copernicus and the University of Kentucky to collaborate on DNA therapy for PD

Jan. 19, 2009

Benefit seen with multi-herbal product Yi-Gan San in vascular dementia patients

Jan. 19, 2009

Intra-Cellular reports top-line phase II ITI-007 results in insomnia

Jan. 19, 2009

Kyowa Hakko Kirin to further evaluate KW-6002 in Japan

Jan. 16, 2009

Savella approved by the FDA for the management of fibromyalgia

Jan. 16, 2009

FDA issues complete response letter for Schering-Plough's NDA for Saphris

Jan. 16, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...